Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-10-29Clinical Trial Update: A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE) [Phase 2]
A 14-week, placebo-controlled Phase 2 study to evaluate the efficacy and safety of NS 2330 (SCEPTRE) in early Parkinson disease as a proof-o…
-
CLINICAL_TRIALS trial_result · 2013-10-29Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Study of NS 2330 (Tesofensine) (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients With Motor Fluctuations [Phase 2]
Phase 2 randomized, double-blind, placebo-controlled study assessing the efficacy and safety of tesofensine (NS 2330) at 0.125, 0.25, 0.5 an…
-
CLINICAL_TRIALS research · 2013-10-24Clinical Trial Update: Comfort and Tolerance of Surface Neuro Muscular Electrical Stimulation in Parkinson's Disease. [NA]
Trial update on the comfort and tolerance of surface neuromuscular electrical stimulation in Parkinson's disease. The status of the trial is…
-
CLINICAL_TRIALS research · 2013-10-23Clinical Trial Update: Freezing of Gait Correction and Fall Prevention: Developing a Real-time Somatosensory Stimulation System [NA]
A clinical trial update on a real-time somatosensory stimulation system designed to correct freezing of gait and prevent falls in Parkinson …
-
FDA approval · 2013-10-11FDA Approved: ENTACAPONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for ENTACAPONE submitted by Sun Pharmaceutical Industries, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-10-10Clinical Trial Update: A Retrospective Study of the Effects of Different Parameters on Motor Symptoms of PD in Bilateral STN Stimulation
A retrospective study examining how different stimulation parameters during bilateral subthalamic nucleus deep brain stimulation affect moto…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's Disease [Phase 4]
Clinical trial NCT01662414, sponsored by Chulalongkorn University, evaluated HMS 90 undenatured cysteine-rich whey protein isolate in Parkin…
-
CLINICAL_TRIALS trial_result · 2013-09-24Clinical Trial Update: Motor Performance in Parkinson's Disease After High Intensive Exercise or Deep Brain Stimulation [NA]
A completed study examining how high-intensity exercise or deep brain stimulation affects motor performance in Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Effect of Robot-assisted Gait Training on Freezing of Gait in Parkinson's Disease [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial evaluating robot-assisted gait training for reducing freezing of gait in Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: Analysis of the Enteric Nervous System Using Colonic Biopsies [NA]
A completed clinical trial analyzed the enteric nervous system using colonic biopsies in Parkinson's disease, multiple system atrophy, and p…
-
CLINICAL_TRIALS trial_result · 2013-09-13Clinical Trial Update: Motor Response to Sildenafil in PD [Phase 4]
Phase 4 trial evaluating whether sildenafil improves motor function in Parkinson's disease; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-09-13Clinical Trial Update: Clinical Trial of Rasagiline in Levodopa-Treated Parkinson's Disease Patients With Motor Fluctuations [Phase 3]
A Phase 3 trial evaluating rasagiline added to levodopa in Parkinson's disease with motor fluctuations has completed.
-
CLINICAL_TRIALS trial_result · 2013-09-09Clinical Trial Update: Study to Compare the Effect of Ropinirole Prolonged Release Once-daily Versus Twice-daily [Phase 4]
A Phase 4 study comparing once-daily ropinirole prolonged-release with a twice-daily regimen in Parkinson's disease has completed and posted…
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: A Triple-blinded, Randomised, Placebo-controlled Trial to Examine the Efficacy and Safety of ViNeuro in Patients With Parkinson's Disease [NA]
A completed, triple-blinded, randomized, placebo-controlled trial evaluating the efficacy and safety of ViNeuro in patients with Parkinson's…
-
CLINICAL_TRIALS trial_result · 2013-09-04Clinical Trial Update: A Single Center, Randomized, Double-blind, Crossover Pilot Trial Comparing the Onset of Action of Parcopa™ With Sinemet® in Subjects With Stable Parkinson's Disease [Phase 3]
Phase 3 randomized, double-blind, crossover trial comparing onset of action of Parcopa with Sinemet in adults with stable Parkinson's diseas…
-
CLINICAL_TRIALS safety_alert · 2013-08-30Clinical Trial Update: a PMS on Safety Profile of Pramipexole in Chinese Parkinson Disease Patients
A completed post-marketing safety surveillance study assessing the safety profile of pramipexole in Chinese patients with Parkinson disease;…
-
CLINICAL_TRIALS research · 2013-08-30Clinical Trial Update: Effects Of Breath And Stacking-Spirometry Incentive in Patients With Parkinson's Disease [NA]
This is a completed clinical trial update examining the effects of breath and stacking-spirometry incentive in Parkinson's disease patients.…
-
CLINICAL_TRIALS trial_result · 2013-08-29Clinical Trial Update: 124I-MIBG Tracer Evaluation of Myocardial Sympathetic Denervation and Assessment of Neuroendocrine Tumors. [Phase 2]
This entry describes a Phase 2 clinical trial evaluating 124I-MIBG tracer for assessing myocardial sympathetic denervation and imaging neuro…
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: Study for Rasagiline Effect on Sleep Trial(REST)in Parkinson's Disease
A clinical trial update indicates the REST study evaluating rasagiline's effect on sleep in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-27Clinical Trial Update: A Randomized Controlled Feasibility Trial to Determine the Effectiveness of Set Dancing for People With Parkinson's Disease [NA]
This randomized feasibility trial evaluated whether set dancing benefits people with Parkinson's disease, and the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-20Clinical Trial Update: Nocturnal Parkinson's Disease Symptoms Study Group
A completed clinical trial update from the Nocturnal Parkinson's Disease Symptoms Study Group investigating Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2013-08-16Clinical Trial Update: Apolipoprotein D (ApoD) In Human Serum As Marker Of Parkinson's Disease
This clinical trial update evaluates apolipoprotein D levels in human serum as a potential biomarker for Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Intravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's Disease [Phase 1]
Phase 1 trial investigating intravenous N-acetylcysteine for Parkinson's disease and Gaucher's disease has completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Deep Brain Stimulation Effects Study [Phase 1]
Phase 1 trial evaluating Deep Brain Stimulation for Parkinson's disease has been terminated.
-
FDA approval · 2013-07-31FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application for Bromocriptine Mesylate, resulting in updated labeling for the product.